PPH Legal Blog

Researchers at the Columbia University College of Physicians and Surgeons have announced a new breakthrough in the fight to treat primary pulmonary hypertension. A recent study of 405 PPH patients that was headed by Dr. Robyn J. Barst suggests that Cialis (generic name tafalafil) may have uses beyond its intended purpose of treated erectile dysfunction. […]

[Read more →]

Yesterday the FDA announced the new “black box” wording for Avandia. The new label has upset many patient advocate groups as it is not a particularly strongly worded new label. They are calling it the latest incidence of the FDA turning a blind eye towards Avandia’s problems.
Avandia’s heart attack risk has been known, apparently, to […]

[Read more →]

Throughout time, people have always sought ways to lose weight quickly with help of additives. Some of the most toxic compounds have been used as weight-loss aids including, but not limited to, mercury and arsenic. Later, people turned to amphetamines to help lose the weight and then realized that these lovely drugs were making them […]

[Read more →]

According to Tomas J Philopson and Eric Sun of the University of Chicago, 55,600 life years have been lost to the speedy approval of drugs following the Prescription Drug User Fee Act. This has been partially attributed to the passage of such drugs as Vioxx, fen-phen, and Baycol. This loss of life translates to between […]

[Read more →]

Suffering from a disease that will affect you for the rest of your life is not something that any one wishes to go through.  Many people like to believe that developing such a disease is something that can not happen to them.  This is not the case, however.  Illness can affect anyone at any time.  […]

[Read more →]